ING Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $1.93M | Sell |
|
|||||
|
2024
Q3 | $24.9M | Sell |
|
|||||
|
2024
Q2 | $31M | Sell |
|
|||||
|
2024
Q1 | $32.2M | Buy |
|
|||||
|
2023
Q4 | $30.6M | Sell |
|
|||||
|
2023
Q3 | $29.6M | Buy |
|
|||||
|
2023
Q2 | $27.6M | Buy |
|
|||||
|
2023
Q1 | $14M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $17.4M | Buy |
|
|||||
|
2022
Q2 | $16.1M | Buy |
|
|||||
|
2022
Q1 | $2.92M | Sell |
|
|||||
|
2021
Q4 | $9.66M | Buy |
|
|||||
|
2021
Q3 | $4.78M | Buy |
|
|||||
|
2021
Q2 | $5.21M | Buy |
|
|||||
|
2021
Q1 | $3.7M | Sell |
|
|||||
|
2020
Q4 | $4.08M | Buy |
|
|||||
|
2020
Q3 | $1.57M | Buy |
|
|||||
|
2020
Q2 | $637K | Sell |
|
|||||
|
2020
Q1 | $3.02M | Buy |
|
|||||
|
2019
Q4 | $359K | Sell |
|
|||||
|
2019
Q3 | $2.72M | Sell |
|
|||||
|
2019
Q2 | $14M | Buy |
|
|||||
|
2019
Q1 | $14M | Buy |
|
|||||
|
2018
Q4 | $11.1M | Buy |
|
|||||
|
2018
Q3 | $4.71M | Sell |
|
|||||
|
2018
Q2 | $5.99M | Sell |
|
|||||
|
2018
Q1 | $7.14M | Sell |
|
|||||
|
2017
Q4 | $8.6M | Buy |
|
|||||
|
2017
Q3 | $6.97M | Sell |
|
|||||
|
2017
Q2 | $7.07M | Buy |
|
|||||
|
2017
Q1 | $5M | Buy |
|
|||||
|
2016
Q4 | $552K | Sell |
|
|||||
|
2016
Q3 | $802K | Buy |
|
|||||
|
2016
Q2 | $204K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $1.12M | Buy |
|
|||||
|
2014
Q4 | $1.12M | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $18.2M | Buy |
|